The round also saw participation from Oncology Ventures, General Catalyst, z21 Ventures, Odd Bird VC, and angel investor Ashish Gupta.
The startup plans to use the capital to deploy its AI-based automation platform across 100 cancer centers in the US over the next two years. Its software aims to reduce delays in treatment caused by prior authorisation processes — a major bottleneck in cancer…